J. Goldman & CO LP Verona Pharma PLC Transaction History

J. Goldman & CO LP

  • $3.35 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$53.9 - $98.68 $1.71 Million - $3.13 Million
-31,680 Reduced 73.68%
11,318 $1.07 Million
Q1 2025

May 15, 2025
BUY
$44.81 - $69.63 $716,870 - $1.11 Million
15,998 Added 59.25%
42,998 $2.73 Million
Q4 2024

Feb 14, 2025
BUY
$28.71 - $47.02 $775,170 - $1.27 Million
27,000 New
27,000 $1.25 Million

Others Institutions Holding VRNA

# of Institutions
264
Shares Held
78.7M
Call Options Held
686K
Put Options Held
442K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email